BNP Paribas Financial Markets’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $118K | Buy |
|
|||||
|
2025
Q2 | $71.6K | Buy |
|
|||||
|
2025
Q1 | $77.1K | Sell |
|
|||||
|
2024
Q4 | $394K | Sell |
|
|||||
|
2024
Q3 | $1.07M | Sell |
|
|||||
|
2024
Q2 | $3.72M | Buy |
|
|||||
|
2024
Q1 | $2.16M | Sell |
|
|||||
|
2023
Q4 | $4.49M | Buy |
|
|||||
|
2023
Q3 | $1.37M | Buy |
|
|||||
|
2023
Q2 | $1.45M | Sell |
|
|||||
|
2023
Q1 | $2.35M | Sell |
|
|||||
|
2022
Q4 | $2.62M | Buy |
|
|||||
|
2022
Q3 | $3.93M | Buy |
|
|||||
|
2022
Q2 | $1.25M | Sell |
|
|||||
|
2022
Q1 | $3.22M | Buy |
|
|||||
|
2021
Q4 | $772K | Sell |
|
|||||
|
2021
Q3 | $1.76M | Buy |
|
|||||
|
2021
Q2 | $59.2K | Sell |
|
|||||
|
2021
Q1 | $221K | Buy |
|
|||||
|
2020
Q4 | $229K | Buy |
|
|||||
|
2020
Q3 | $121K | Sell |
|
|||||
|
2020
Q2 | $974K | Sell |
|
|||||
|
2020
Q1 | $1.71M | Buy |
|
|||||
|
2019
Q4 | $453K | Sell |
|
|||||
|
2019
Q3 | $378K | Buy |
|
|||||
|
2019
Q2 | $320K | Sell |
|
|||||
|
2019
Q1 | $209K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $30.3K | Hold |
|
|||||
|
2018
Q2 | $34.4K | Sell |
|
|||||
|
2018
Q1 | $251K | Buy |
|
|||||
|
2017
Q4 | $100K | Buy |
|
|||||
|
2017
Q3 | $47.6K | Sell |
|
|||||
|
2017
Q2 | $47.3K | Buy |
|
|||||
|
2017
Q1 | $3.34K | Sell |
|
|||||
|
2016
Q4 | $22.7K | Sell |
|
|||||
|
2016
Q3 | $30.7K | Buy |
|
|||||
|
2016
Q2 | $14.3K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $68.9K | Sell |
|
|||||
|
2015
Q3 | $57.4K | Buy |
|
|||||
|
2015
Q2 | $34.4K | Buy |
|